Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213218 | PMC |
http://dx.doi.org/10.1016/j.jdcr.2022.05.008 | DOI Listing |
Skin Res Technol
October 2024
Tianjin Children's Hospital/Children's Hospital, Tianjin University, Tianjin, China.
J Med Case Rep
September 2024
Department of Dermatology, Wuhan No. 1 Hospital, Wuhan, 430022, China.
J Cosmet Dermatol
December 2024
Department of Plastic and Reconstructive Surgery, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China.
Acta Dermatovenerol Croat
March 2024
Marco Brusasco, MD, University of Parma, Via Gramsci 14, Parma, Italy;
J Cosmet Dermatol
September 2024
Department of Dermatology, The First Affiliated Hospital, Kunming Medical University, Kunming, Yunnan, China.
Objective: To assess the effectiveness and safety of treating erythematotelangiectatic rosacea using fractional radiofrequency (FRF).
Methods: Twenty patients with a confirmed diagnosis of erythema capillaris rosacea were selected, and one side of each patient's face was randomly assigned to receive FRF treatments for three to six times, with an interval of 2 weeks between each treatment. VISIA, dermoscopy, and the Clinician's Erythema Evaluation Scale (CEA) were applied to evaluate the efficacy of the treatment before and after the treatment, to record the VAS scores and adverse reactions, and to conduct a patient satisfaction survey.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!